The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $89.92

Today's change-0.68 -0.75%
Updated September 26 4:01 PM EDT. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $89.92

Today's change-0.68 -0.75%
Updated September 26 4:01 PM EDT. Delayed by at least 15 minutes.

CVS Health Corp down (U.S.)$0.68

CVS Health Corp closed lower Monday, dropping (U.S.)$0.68 or 0.75% to (U.S.)$89.92. Over the last five days, shares have gained 0.84%, but sit 3.95% above the 52-week low. Shares have underperformed the S&P 500 by 19.93% during the last year.

Key company metrics

  • Open(U.S.) $90.08
  • Previous close(U.S.) $90.60
  • High(U.S.) $90.38
  • Low(U.S.) $89.49
  • Bid / Ask(U.S.) $89.82 / (U.S.) $90.00
  • YTD % change-8.03%
  • Volume4,722,056
  • Average volume (10-day)6,201,586
  • Average volume (1-month)4,979,257
  • Average volume (3-month)5,218,214
  • 52-week range(U.S.) $86.50 to (U.S.) $106.67
  • Beta0.82
  • Trailing P/E20.69×
  • P/E 1 year forward15.46×
  • Forward PEG1.06×
  • Indicated annual dividend(U.S.) $1.70
  • Dividend yield1.89%
  • Trailing EPS(U.S.) $4.35
Updated September 26 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.53%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue43,72543,21541,14638,644
Total other revenue--------
Total revenue43,72543,21541,14638,644
Gross profit7,0156,7447,3016,661
Total cost of revenue36,71036,47133,84531,983
Total operating expense41,91741,03938,41736,313
Selling / general / administrative4,6654,5684,5724,330
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)542--00
Other operating expenses, total--------
Operating income1,8082,1762,7292,331
Interest income (expense), net non-operating-284-288-282-268
Gain (loss) on sale of assets--------
Other--------
Income before tax1,5281,8932,4532,070
Income after tax9241,1471,5001,237
Income tax, total604746953833
Net income9241,1461,4981,246
Total adjustments to net income-4-6----
Net income before extra. items9241,1461,4991,236
Minority interest0-1-1-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9201,1401,4991,236
Inc. avail. to common incl. extra. items9201,1401,4981,246
Diluted net income9241,1401,4981,246
Dilution adjustment4------
Diluted weighted average shares1,0751,0991,1141,121
Diluted EPS excluding extraordinary itemsvalue per share0.861.041.351.10
Dividends per sharevalue per share0.430.430.350.35
Diluted normalized EPSvalue per share1.161.041.351.10